Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.

Maria Isabel LopesLeticia P BonjornoMarcela C GianniniNatalia B AmaralPamella Indira MenezesSaulo Musse DibSamara Libich GiganteMaira N BenattiUebe C RezekLaerte L Emrich-FilhoBetania A A SousaSergio C L AlmeidaRodrigo L AssadFlavio P VerasAyda SchneiderTamara S RodriguesLuiz O S LeiriaLarissa D CunhaJose C Alves-FilhoThiago M CunhaEurico ArrudaCarlos H MirandaAntonio Pazin-FilhoMaria Auxiliadora-MartinsMarcos C BorgesBenedito A L FonsecaValdes R BollelaCristina M Del-BenFernando Q CunhaDario S ZamboniRodrigo C SantanaFernando C VilarPaulo Louzada-JuniorRenê Donizeti Ribeiro de Oliveira

Published in: RMD open (2021)

RBR-8jyhxh.

Keyphrases

double blind
placebo controlled
clinical trial
coronavirus disease
phase ii
sars cov
phase iii
study protocol
open label
high intensity
early onset
phase ii study
respiratory syndrome coronavirus